Abstract
We have examined the molecular basis of three cases of severe mental retardation with autistic features in one family. A point mutation in a purine nucleotide biosynthetic enzyme, adenylosuccinate lyase (ASL), segregates with the disorder. The affected children are homozygous for the point mutation while the parents and all four unaffected children are heterozygous. The point mutation is absent in control subjects. The point mutation results in a Ser413 Pro substitution which leads to structural instability of the recombinant mutant enzyme, and this instability lowers ASL levels in lymphocytes. These observations suggest that the instability of ASL underlies the severe developmental disorder in the affected children, and that mutations in the ASL gene may result in other cases of mental retardation and autistic features.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jaeken, J. & van den Berghe, G. Lancet ii, 1058–1061 (1984).
Jaeken et al. Eur. J. Pediatr. 148, 126–131 (1988).
Barshop, B., Alberts, A. & Gruber, H. Biochim. Biophys. Acta 999, 19–23 (1989).
Aimi, J. et al. Nucl. Acids Res. 18, 6665–6672 (1990).
Chen, Z., Dixon, J.E. & Zalkin, H. Proc. natn. Acad. Sci. U.S.A. 87, 3097–3101 (1990).
Aimi, J. et al. J. biol. Chem. 265, 9011–9014 (1990).
Ni, L., Guan, K., Zalkin, H. & Dixon, J.E. Gene (in the press).
Tiedeman, A.A. & Smith, J.M. Gene 97, 289–293 (1991).
Tabor, S. & Richardson, C.C. Proc. natn. Acad. Sci. U.S.A. 82, 1074–1078 (1985).
Brox, L.W. Can. J. Biochem. 51, 1072–1076 (1973).
Bridger, W.A. & Cohen, L.H. J. biol. Chem. 243, 644–650 (1968).
Pace, C.N., Shirley, B.A. & Thomson, J.A. Protein Structure, a Practical Approach (ed. Creighton, T. A.)(IRL Press, Oxford, 1989).
Danielsen, C.C. Biochem. J. 272, 697–701 (1990).
Parsell, D.A. & Sauer, R.T. J. biol. Chem. 264, 7590–7595 (1989).
Karplus, P.A. & Schulz, G.E. Naturwissenschaften 72, 212–213 (1985).
Van den Bergh, F., Vincent, M.F., Jaeken, J. & Van den Berghe, G. Anal. Biochem. 193, 287–291 (1991).
Jaeken, J., Van den Bergh, F., Vincent, M. F., Casaer, P. & Van den Berghe, G. J. Inher. Metab. Dis. (in the press).
Van den Bergh, F., Vincent, M.F., Jaeken, J. & Van den Berghe, G. Anal. Biochem. 193, 287–291 (1991).
Jaeken, J., Van den Bergh, F., Vincent, M. F., Casaer, P. & Van den Berghe, G. J. Inher. Metab. Dis. (in the press).
Short, J.M., Fernandez, J.M., Sorge, J.A. & Huse, W.D. Nucl. Acids Res. 16, 7583–7600 (1990).
Burgess, R. & Jendrisak, J. J. Biochem. 14, 4634–4638 (1975).
Towbin, H., Staehelin, T. & Gordon, J. Proc. natn. Acad. Sci. U.S.A. 76, 4350–4354 (1979).
Bradford, M.M. Anal. Biochem. 72, 248–254 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stone, R., Aimi, J., Barshop, B. et al. A mutation in adenylosuccinate lyase associated with mental retardation and autistic features. Nat Genet 1, 59–63 (1992). https://doi.org/10.1038/ng0492-59
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0492-59
- Springer Nature America, Inc.
This article is cited by
-
Clinical and molecular characterization of patients with adenylosuccinate lyase deficiency
Orphanet Journal of Rare Diseases (2021)
-
Molecular comparison of Neanderthal and Modern Human adenylosuccinate lyase
Scientific Reports (2018)
-
Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines
Scientific Reports (2017)
-
Adenylosuccinate lyase deficiency
Journal of Inherited Metabolic Disease (2015)
-
Advances in Genetic Discovery and Implications for Counseling of Patients and Families with Autism Spectrum Disorders
Current Genetic Medicine Reports (2014)